Navigation Links
BIO-key(R) Reports First Quarter 2008 Results
Date:5/15/2008

Continued Growth in Biometrics Business in First Quarter

WALL, N.J., May 15 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, today announced its financial results for the first quarter ended March 31, 2008.

2008 First Quarter Consolidated Results

Total revenue from continuing operations for the three months ended March 31, 2008 was $2.5 million representing a decrease of 3.8% from the $2.6 million reported for the quarter ended December 31, 2007.

BIO-key's gross margin for the first quarter of 2008 was 82.6% compared to 85.6% for the previous quarter. Operating expenses from continuing operations for the first quarter of 2008 remained flat at $3.0 million compared to the quarter ended December 31, 2007. BIO-key's operating loss from continuing operations for the first quarter of 2008 increased by $0.3 million to ($0.9 million) from ($0.6 million) reported in the previous quarter.

"Our quarterly results continue to reflect growing demand in our biometrics business which we began to see several quarters ago," said Michael DePasquale, BIO-key's Chief Executive Officer. "During the first quarter of 2008, the Company recognized revenue on several large commercial biometric orders, as well as from an international voter registration order. We believe these orders indicate an inflection point in the growth of our biometrics business in the coming quarters of this year. We are also very excited about the prospects for our recently deployed initiative with wireless carriers on handheld devices tailored for public safety use. This business opportunity enables us to leverage our broad installed base in public safety to drive sales."

DePasquale concluded, "We are seeing unprecedented industry-wide interest in biometrics and wireless applications. I believe the market is finally catching up to our value pr
'/>"/>

SOURCE BIO-key International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology news :

1. BIO-key(R) Receives $335,000 Contract Award From Baltimore Police
2. BIO-key(R) Announces First Quarter 2008 Earnings Release and Conference Call Schedule
3. BIO-key(R) Showcasing Public Safety Solutions for BlackBerry Smartphones at 2008 LEIM Conference
4. BIO-key(R) Granted Image Identification System Patent for Award Winning Biometric Technology
5. BIO-key(R) Awarded Mobile Data Contract for Additional 10 Kentucky Law Enforcement Agencies
6. BIO-key(R) Receives New Mobile Data Contract Award From Indiana Police Agency
7. BIO-key(R) to Showcase Biometric Identification Technology at 2008 RSA Conference
8. BIO-key(R) to Showcase Biometric Identification Technology at 2008 RSA Conference
9. BIO-key(R) Receives New Mobile Data Contract Award From Indiana Police Agency
10. BIO-key(R) Announces Fourth Quarter and Full Year 2007 Earnings Release and Conference Call Schedule
11. San Diego Harbor Police Deploy BIO-key(R) Automated Vehicle Location System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...rasitica is an international journal that publish...al, chemical and molecular aspects of entomology, ...ences, including insecticides, fungicides, herbici...ches in the control of pests and diseases. , Ph...earch notes and book reviews. Guest editorials wr...
(Date:1/7/2009)...PHIA A study published in Cancer Prevention Rese...ancer Research, identifies components of black ras...rchers at the Ohio State Comprehensive Cancer Cent...in black raspberries, inhibited growth and stimula...h an esophageal carcinogen. , "Our data provide...
(Date:1/7/2009)...cular details of Aromatase, the key enzyme require...ystery thanks to the structural biology work done ...Research Institute (HWI) in Buffalo, New York. Dr...al structure of aromatase is the first time that s...m of synthesizing estrogen. , In fact, the Ghos...
(Date:1/7/2009)...University of Colorado at Boulder study shows the ... of antiviral drugs is increasing through positive...ing the trend in more than 30 percent of the sampl...pe dubbed H5N1, is evolving a resistance to a grou...two classes of antiviral drugs used to prevent and...
Breaking Biology News(10 mins):Springer expands its portfolio in plant sciences with Phytoparasitica 2HWI scientist first in world to unravel structure of key breast cancer target enzyme 2HWI scientist first in world to unravel structure of key breast cancer target enzyme 3Avian flu becoming more resistant to antiviral drugs, says University of Colorado study 2Avian flu becoming more resistant to antiviral drugs, says University of Colorado study 3PEGINTRON 28TM 29 and REBETOL 28R 29 Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non Pegylated Int 6391 1PEGINTRON 28TM 29 and REBETOL 28R 29 Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non Pegylated Int 6391 2PEGINTRON 28TM 29 and REBETOL 28R 29 Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non Pegylated Int 6391 3PEGINTRON 28TM 29 and REBETOL 28R 29 Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non Pegylated Int 6391 4PEGINTRON 28TM 29 and REBETOL 28R 29 Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non Pegylated Int 6391 5PEGINTRON 28TM 29 and REBETOL 28R 29 Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non Pegylated Int 6391 6PEGINTRON 28TM 29 and REBETOL 28R 29 Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non Pegylated Int 6391 7PEGINTRON 28TM 29 and REBETOL 28R 29 Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non Pegylated Int 6391 8Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD 6388 1Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD 6388 2Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD 6388 3Fetal heart rate yields clues to childrens later development 6385 1Fetal heart rate yields clues to childrens later development 6385 2Family conditions may affect when girls experience puberty 1231 1Family conditions may affect when girls experience puberty 1231 2
... the University at Buffalo have shown for the firs...ungal agent in saliva, kills the oral pathogen Can...-related oral infections. , Researchers led by Mi...in binds to a specific membrane protein called TRK... cell membrane of the pathogenic fungus Candida al...
...eem to occur on Earth roughly every 26 million yea...ay be caused by rare collisions with comets or ast...ssible that extraordinary predators are at fault i...y) constructed a numerical model of many species c... also included a term that controls mutation rates...
...sed at Massachusetts General Hospital (MGH) has id...RNA interference (RNAi), a powerful new research t...hey used the RNAi process itself to find new genes... which someday may help to fight human disease. Th... receiving early online release on the Science Exp...
... that exposure to harmful chemicals and drugs duri...y actually "reprogram" the way certain genes respo...programming may determine whether people with a ge...p the disease. , The new research shows that when ...rs also receive an early-life exposure to diethyls...
Other Biology News:Discovery may lead to better Candidiasis drug 2Scientists identify genetic pathways essential to RNA interference 2Scientists identify genetic pathways essential to RNA interference 3Harmful chemicals may reprogram gene response to estrogen 2Harmful chemicals may reprogram gene response to estrogen 3
(Date:1/8/2009)..., CLINTON, N.J., Jan. 8 Ikaria Hol...p; CEO, Daniel Tasse, will present at the 27th Ann...anuary 14, 2009 at 8:00 a.m., PST. The conference...cis Hotel in San Francisco. , , About Ikaria H... integrated biotherapeutics company focused on the...
(Date:1/8/2009)..., MONTREAL, Jan. 8 /PRNewswire/ - Aegera Therapeut...atient in a randomized Phase 2 study of AEG35156, ...development for multiple oncology indications. , ...Label, Randomized Study of the X-Linked Inhibitor ...mbination With Carboplatin/Paclitaxel or the Combi...
(Date:1/8/2009)..., Webcast Presentation Scheduled for Wednesday, Ja..., Colo. and SAN CARLOS, Calif., Jan. 8 /PRNewswire...utical company developing genetically-targeted the...diseases, and Nuvelo, Inc. (Nasdaq: NUVO ) today...nd chief executive officer, will present at the 27...
(Date:1/8/2009)..., MOUNTAIN VIEW, Calif., Jan. 8 Co...es for clot removal in ischemic stroke patients, t... round of financing. The round was led by leading...nc. (NEA) and includes other existing investors an... at Concentric over the last several months made t...
Breaking Biology Technology:Ikaria(R) to Present at 27th Annual JPMorgan Healthcare Conference 2Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer 2ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 2ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 3ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 4ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 5Concentric Medical Closes on $15 Million Financing 2
... hNT Neurons used to imitate neurodegeneration ...N.Y. Zachariah a Walter J. McConathy a,b , a D...,Sciences, ,University of North Texas Health S...novative technique that uses Stratagenes,postmit...ons) to imitate the,aging human brain, neurodege...
... ,, Seamless insertion and one-step pu...Level Protein Expression, One-Column Purification,...rine Felts Denise Wyborski John Bauer Peter,V...ved the Affinity LIC cloning kit,with the new...expression,vector is designed for consistent, hi...
... ,,,, Retroviral libraries w...ntial , Functional Cloning Using ,ViraPort Re...elts Kim Zaharee Latha Sundar Jamie,Limjoco ,..., We introduce a set of human cDNA expression lib...ector pFB. ViraPort retroviral,libraries allow...
... ,,,,, Reliable, PCR-based...inz Miller Ian Colbert ,Stratagene , Stratage... a,kit that uses a PCR-based method which speci...ingle copy gene. In addition, the kit contains an ...ive control for PCR. The kit offers a,rapid and ...
Other Biology Technology:Sex Steroid Regulation of Vasopressin Levels Secreted by hNT Neurons* 2Sex Steroid Regulation of Vasopressin Levels Secreted by hNT Neurons* 3Sex Steroid Regulation of Vasopressin Levels Secreted by hNT Neurons* 4Sex Steroid Regulation of Vasopressin Levels Secreted by hNT Neurons* 5Sex Steroid Regulation of Vasopressin Levels Secreted by hNT Neurons* 6Sex Steroid Regulation of Vasopressin Levels Secreted by hNT Neurons* 7High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 2High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 3High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 4High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 5High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 6High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 7High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 8Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 2Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 3Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 4Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 5Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 6Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 7Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 8Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 9Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 10Functional Cloning Using,ViraPort Retroviral cDNA Expression Libraries 11A New PCR-based Mycoplasma Detection Method 2A New PCR-based Mycoplasma Detection Method 3A New PCR-based Mycoplasma Detection Method 4A New PCR-based Mycoplasma Detection Method 5A New PCR-based Mycoplasma Detection Method 6
Unit Definition: 1 U corresponds to the amount of enzyme which produces 1 mol protons per minute at pH 5.5 and 30C (peptin from citrus peel, Fluka-No. 76280, as substrate)
Pyruvate Kinase. This product is expected to react with pyruvate kinase from other mammalian species but has not been specifically determined. Specificity: Gives a single precipitin line against pa
Rabbit polyclonal to Somatostatin 28 ( Abpromise for all tested applications). entrezGeneID: 6750 SwissProtID: P61278
Features Convenient platform for tube handling and reagent dispensing Holds: - 96 x 0.2ml V-bottom tubes - 96 x 0.3ml U-bottom Omnistrips - Thermo-Tube Plates - Thermo-Fast®
Biology Products: